Brian Poff Sells 2,041 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Brian Poff sold 2,041 shares of the business’s stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $218,346.18. Following the completion of the sale, the executive vice president owned 64,512 shares of the company’s stock, valued at approximately $6,901,493.76. This trade represents a 3.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Brian Poff also recently made the following trade(s):

• On Wednesday, February 25th, Brian Poff sold 820 shares of Addus HomeCare stock. The stock was sold at an average price of $105.36, for a total value of $86,395.20.

Addus HomeCare Trading Down 0.5%

ADUS opened at $103.53 on Friday. The stock has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.87, a P/E/G ratio of 1.44 and a beta of 0.91. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The company has a 50-day simple moving average of $109.22 and a 200 day simple moving average of $112.95.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Invesco Ltd. boosted its holdings in shares of Addus HomeCare by 7.1% during the 4th quarter. Invesco Ltd. now owns 416,857 shares of the company’s stock valued at $44,766,000 after acquiring an additional 27,683 shares in the last quarter. Caitlin John LLC bought a new position in Addus HomeCare in the fourth quarter valued at about $183,000. Empowered Funds LLC raised its position in Addus HomeCare by 186.1% in the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after purchasing an additional 46,137 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Addus HomeCare during the fourth quarter valued at about $432,000. Finally, VARCOV Co. bought a new stake in shares of Addus HomeCare during the fourth quarter worth about $382,000. 95.35% of the stock is currently owned by institutional investors.

Key Stories Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on ADUS shares. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Stephens lowered their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday. Truist Financial set a $135.00 price objective on Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday, January 7th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $134.33.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.